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Abstract
Accumulating evidence indicates that oxidative stress plays a critical role in Parkinson `s disease (PD). Our previous work has
shown that 100 Hz electro-acupuncture (EA) stimulation at ZUSANLI (ST36) and SANYINJIAO (SP6) protects neurons in the
substantia nigra pars compacta from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in male C57BL/6 mice, a
model of PD. In the present study we administered 100 Hz EA stimulation at the two acupoints to MPTP-lesioned mice for
12 sessions starting from the day prior to the first MPTP injection. We found that in the striatum of MPTP treated mice
100 Hz EA stimulation effectively inhibited the production of hydrogen peroxide and malonaldehyde, and increased
glutathione concentration and total superoxide dismutase activity through biochemical methods. However, it decreased
glutathione peroxidase activity via biochemical analysis and did not affect the level of 1-methyl-4-phenylpyridinium in the
striatum revealed by high performance liquid chromatography with ultraviolet detection. These data suggest that 100 Hz
EA stimulation at ST36 and SP6 has antioxidative effects in the MPTP model of PD. This data, along with our previous work,
indicates that 100 Hz EA stimulation at ST36 and SP6 protects the nigrostriatal system by multiple mechanisms including
antioxidation and antiapoptosis, and suggests that EA stimulation is a promising therapy for treating PD.
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Introduction
Parkinson’s disease (PD) is a common neurodegenerative disease
characterized by motor disorders resulting from the profound loss
of dopaminergic neurons in the substantia nigra pars compacta
(SNpc) and the subsequent depletion of dopamine (DA) in the
striatum. Though significant progress has been made in the
treatment of PD, no therapy has been proven to halt or slow
disease progression or provide long-term improvement. Numerous
investigations have focused on decoding the pathogenesis of PD in
an attempt to find a therapeutic strategy. Several postmortem
studies show that markers for lipid peroxidation, oxidative DNA
and protein damage are significantly increased in the substantia
nigra (SN) of PD patients [1–5], indicating that oxidative stress
plays an important role in the pathogenesis of PD [6].
Administration of the toxin 1-methyl-4-phenyl-1,2,3,6-tetrahy-
dropyridine (MPTP) causes neurochemical, behavioral, and
histopathological alterations in human and nonhuman primates
that replicate very closely the clinical symptoms of PD patients, so
MPTP is widely used to produce animal models of PD [7]. MPTP
is highly lipophilic and crosses the blood-brain barrier soon after
systemic administration. In the brain MPTP is metabolized to 1-
methyl-4-phenylpyridinium (MPP
+), the active toxic compound.
The formation and toxic production process of MPP
+ are
accompanied by an increased production of free radicals,
especially superoxide [8,9], which is poorly reactive but can be
turned into hydrogen peroxide (H2O2). H2O2 participates in
MPTP injury through forming hydroxyl radicals [10], the potent
oxidants that attack DNA, protein and membrane lipids leading to
cell death. Previous studies have suggested that antioxidants could
protect DA neurons in the SNpc from MPTP injury [11–13],
indicating that antioxidant therapy might be a potential
therapeutic choice for PD.
Accumulating clinical evidences have demonstrated that
acupuncture helps to improve movement disabilities and reduce
the dosage of drugs required by PD patients [14–16]. ZUSANLI
(ST36) and SANYINJIAO (SP6) are often used by acupuncturists
to treat PD patients at their clinics on the basis of ancient theories
of Traditional Chinese Medicine. Modern science research had
shown that stimulation in these two acupoints could enhance the
immunity and improve the mobility [17–20]. However, the
underlying mechanisms are still unclear.
In this study, we hypothesized that the acupuncture stimulation
has neuroprotective effect on DA neurons and this effect is
stimulation frequency-dependent and is related to the antioxida-
tive effect of acupuncture. We tested this hypothesis by evaluating
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19790the DA neuron quantity, the oxidative damage and levels of
antioxidants after different frequency EA stimulation at ST36 and
SP6 in MPTP treated mice.
Materials and Methods
Ethics statement
All animal experiments were performed by Haomin Wang,
whose permit number of License for Performing Animal
Experiments of Beijing, which is approved and required by the
Ethics Committee of Peking University Health Science Center (a
branch committee of the Committee on Animal Care and Usage
of Peking University Health Science) before conducting animal
experiments in Peking University Health Science Center, is 12928.
Animals
Male C57BL/6 mice weighing 22,25 g were supplied by the
Laboratory Animal Center of Peking University, and housed in a
temperature-controlled room (2361uC) under 12-h on/off light
cycle with food and water ad libitum in the home cage. Mice were
allowed to acclimate to their home environment for 7 days before
experiments.
EA stimulation
Mice were randomly divided into five groups: saline (NS), saline
plus EA stimulation at 100 Hz (100 Hz + NS), MPTP, MPTP plus
EA stimulation at 0 Hz or 100 Hz (0 Hz + MPTP and 100 Hz +
MPTP respectively). The EA stimulation was performed from day 1
to day 13 except day 7 (Figure 1) as described before [21] with
minor modifications. The mouse was gently restrained in a
polyethylene cylinder with its hind limbs and tail outside. Two
sterilized stainless-steel needles 0.18 mm in diameter and 3 mm
long were inserted in each leg, one at ST36 (2 mm lateral to the
anterior tubercle of tibia) and the other at SP6 (2 mm proximal to
the upper border of medial melleolus, at the posterior border of the
tibia). Bidirectional square wave electrical pulses (0.2 ms duration,
100 Hz) or no electrical pluses (0 Hz), designated as EA, were given
for a total of 30 min each day. The intensity of the stimulation at
100 Hz was increased stepwise from 1 to 1.25 mA and then to 1.5
mA, with each step lasting for 10 min. The animals remained
relaxed during stimulation, so anesthesia was not performed.
MPTP treatments
Following EA stimulation mice received intraperitoneal (i.p.)
injections of MPTP from day 2 to day 6 (Figure 1) (Sigma-Aldrich,
St. Louis, MO, USA, 30 mg/kg, dissolved in saline, once a day) or
an equivalent volume of saline.
Tissue collection and processing
Three mice from each group were randomly selected on day 14
for tyrosine hydroxylase (TH) immunohistochemistry. They were
deeply anesthetized with 400 mg/kg chloral hydrate, and then
transcardially perfused with 25 ml saline followed by 75 ml 4%
(w/v) paraformaldehyde in phosphate buffer. Brains were
removed and post-fixed in the same fixative overnight and then
cryoprotected in 30% (w/v) sucrose for 3 , 5 days. The brains
were frozen on powdered dry ice and then arranged for frontal
sectioning according to the mouse brain atlas of Burton M.
Slotnick and Christina M. Leonard. Brains were sectioned at
20 mm thickness with a cryostat at 220uC and processed for
immunohistochemistry. On day 2 (2 hr. post MPTP injection), 3
(4 hr. post MPTP injection), 6 (2 hr. post MPTP injection), 7 and
14, seven to eight mice from each group were decapitated, and the
bilateral striata and the ventral midbrains were dissected quickly
and stored at 280uC (Figure 1).
Immunohistochemistry and quantification of TH-ir
neuronal profiles
All sections spanning the SN were collected for immunohisto-
chemistry according to the previously described method [22] with
minor modifications. Every seventh section was incubated in
rabbit anti-TH antibody (1:2000, Chemicon, Temecula, CA,
USA) at 4uC overnight. Sections treated with diluted non-immune
goat serum instead of primary antibody served as an antibody
control. Sections were incubated with biotinylated goat anti-rabbit
antibody and then with the avidin–biotin–peroxidase complex for
30 min at 37 uC. The bound complex was visualized by incubating
sections in a solution containing 0.1% (w/v) 3,3-diaminobenzidine
(Sigma, St. Louis, MO, USA), 1% (v/v) H2O2, and 8% (w/v)
ammonium nickel sulfate (Fluka Chemie GmbH, Switzerland).
TH-ir neuronal profiles with distinct nuclei were counted in ten
sections throughout the entire rostrocaudal extent of the SNpc. All
sections were coded and examined blind.
HPLC analysis of dopamine and its metabolites
Striata collected on day 14 were used to detect the levels of DA
and its metabolites, dihydroxyphenylacetic acid (DOPAC) and
homovanillic acid (HVA), by HPLC with electrochemical
detection (HPLC-ECD). In brief, tissues were weighed and then
homogenized in 0.4 M ice-cold perchloric acid (150 ml/tissue). All
homogenates were kept away from light in an ice bath for 60 min.
Centrifuging at 12,000 rpm and 4uC for 20 min, transferring
120 ml supernatant from each sample to a new tube and then
adding 60 ml solution (20 mM potassium citrate, 300 mM
potassium dihydrogen phosphate, and 2 mM EDTA-2Na).
Keeping the mixtures away from light in an ice bath for 60 min,
and then centrifuging at 12,000 rpm and 4uC for 20 min. Filtering
the supernatant with a 0.22 mm Millipore filter and injecting the
filtrate into the HPLC system for analysis. The mobile phase
contained 110 mM citrate buffer/100 mM EDTA/70 mM 1-
octanesulfonate sodium solution and 20% (v/v) methanol. Flow
rate was 1 ml/min. Striata from six to nine animals in each group
were used.
H2O2, MDA, total SOD, GSH, and GSH-PX assay
On day 3, 7 and 14 mice were sacrificed and the striata as well
as the ventral midbrains were dissected as described above. About
seven striata and ventral midbrains from each group were
homogenized in 30 vol. (wt./vol.) of 0.1 M phosphate buffer
solution and centrifuged at 3000 g and 4uC for 15 min. The
supernatant was used to determine the level of H2O2, malonalde-
hyde (MDA) and activity of total superoxide dismutase (SOD).
The supernatant from the striata and the ventral midbrains diluted
in 10 vol. (wt./vol.) buffer was used for glutathione peroxidase
(GSH-PX) activity assay. H2O2, MDA, SOD and GSH-PX assays
were performed according to the procedures provided by the assay
Figure 1. Experimental design of the study. Numbers represent
days.
doi:10.1371/journal.pone.0019790.g001
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China). The glutathione (GSH) content was detected by a Total
Glutathione Quantification Kit (Dojindo Laboratories, Kuma-
moto, Japan), following the kit `s instructions. H2O2 content was
determined by monitoring at the absorbance at 412 nm of the
titanium-peroxide complex [23]. MDA level was analyzed with 2-
thiobarbituric acid [24]. SOD activity was analyzed by monitoring
the inhibition of the reduction of nitro blue tetrazolium by the
sample at 550 nm [25]. GSH-PX activity was detected with 5-59-
dithiobis-p-nitrobenzoic acid [26]. GSH level was measured by
DTNB-GSSG reductase recycling assay [27]. All the assays were
colorimetric methods based on biochemical reactions, and the
absorbance values of the samples were calibrated against that of
the standards with known concentration or calibrated to a
standard graph generated with known content of the standards.
MPP
+ measurement
Striata collected on day 2 and 6 (2 hr. after the first and last
injection of MPTP) were used for measuring MPP
+ level using
HPLC with UV detection (HPLC-UV, wavelength, 293 nm).
Samples were weighed, homogenized in 200 ml ice-cold perchloric
acid (0.1 M). and then centrifuged at 12,000 rpm at 4uC for
7 min. The supernatant was filtered prior to analysis by HPLC.
For HPLC analysis the mobile phase contained 85% (v/v) 0.1 M
acetic acid/75 mM triethylamine solution and 15% (v/v)
acetonitrile and the flow rate was 1 ml/min.
Statistical analysis
Values are expressed as mean 6 SEM. Differences among
means were analyzed using one-way ANOVA followed by
Newman–Keuls post hoc test of difference between means. A p
value ,0.05 denoted a statistically significant difference.
Results
100 Hz EA stimulation protects dopaminergic neurons
from MPTP toxicity
Profound loss of DA neurons in the SNpc is the main
pathological change of PD. Here we assessed whether EA
stimulation could rescue DA neurons in the SNpc from MPTP
toxicity by TH immunohistochemistry. We found that on day 14,
TH positive neurons in MPTP treated mice dramatically
decreased (p,0.05 vs. NS group; Figure 2, E and F), in comparison
with the saline group (Figure 2, A and B). However, TH
immunoreactivity could be rescued by 100 Hz EA stimulation
(p,0.05 vs. MPTP group; Figure 2, I and J). Unlike 100 Hz, EA
stimulation at 0 Hz made no difference (Figure 2, G and H).
Furthermore, 100 Hz EA stimulation had no effect on saline
treated control mice (Figure 2, C and D). These results suggest that
100 Hz EA stimulation can protect DA neurons in the SNpc from
MPTP injury.
100 Hz EA stimulation increases the concentration of
striatal DA and its metabolites in PD mice
Because the abnormal motor function in PD is mainly caused by
subthreshold levels of DA in the striatum, we looked at the
concentration of striatal DA and its metabolites, DOPAC and
HVA in our different groups. On day 14, MPTP injection caused
a significant reduction in the concentration of the three substances
(p,0.001 vs. NS group, Figure 3). However, 100 Hz EA
Figure 2. 100 Hz EA stimulation protects dopaminergic neurons from MPTP toxicity. (A and B) NS. (C and D) 100 Hz + NS. (E and F) MPTP.
(G and H) 0 Hz + MPTP. (I and J) 100 Hz + MPTP. (K) Quantification of TH positive neuronal profiles in the SNpc. *p,0.05, compared with NS group.
n=3. Scale bar, 200 mm (A, C, E, G and I) and 50 mm (B, D, F, H and J).
doi:10.1371/journal.pone.0019790.g002
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vs. MPTP group, Figure 3A) in the MPTP treated mice, as well as
DOPAC and HVA concentrations (19.8% and 22.9% increase
respectively, p,0.05 vs. MPTP group; Figure 3, B and C).
Consistent with the TH immunohistochemistry results, 0 Hz EA
stimulation did not affect the concentrations of DA, DOPAC and
HVA in the striatum of the MPTP treated mice.
100 Hz EA stimulation inhibits the elevation of striatal
H2O2 level in PD model mice
In our model, striatal H2O2 content increased significantly at
2 hr. after a single MPTP injection and reached its peak at 4 hr.
(Figure S1). Measurement of striatal H2O2 level at 4 hr. after every
MPTPinjection(fiveinjectionsintotal) show that only thefirstthree
MPTP injections augment H2O2 levels significantly (Figure S1 and
S2).Therefore we examined striatal H2O2 level on day3 when mice
had been given two MPTP injections. The results show that 100 Hz
EA stimulation inhibits the elevation of H2O2 in MPTP treated
mice (p,0.05 vs. MPTP group, Figure 4), while, 0 Hz EA
stimulation has no affects. Additionally, 100 Hz EA stimulation
had no effect on normal mice. Moreover, we observed there was no
significant change of H2O2 contents in the ventral midbrain of the
model mice compared with the NS group (Figure S3 and S4).
Since all of our above tests show that 100 Hz EA stimulation
had no adverse effect on normal mice and 0 Hz EA stimulation
did not have an effect on MPTP treated mice, we abandoned the
100 Hz + NS and 0 Hz + MPTP groups in order to minimize the
number of animals used in the following experiments.
Effects of 100 Hz EA stimulation on the concentration/
activity of striatal GSH, GSH-PX and SOD
In the brain, major antioxidant defenses consist of antioxidant
scavengers such as GSH and enzymes such as GSH-PX and
SOD. For the following experiment we measured striatal
concentration and activity of GSH, GSH-PX and total SOD
on day 3, 7 and 14.
On day 3 EA stimulation enhanced GSH content significantly
(p,0.001 vs. NS and p,0.001 vs. MPTP group on day 3,
Figure 5A), but the effect disappeared on day 7 and 14. MPTP
injection did not affect GSH content in the striatum.
GSH-PX activity was significantly increased on day 3 in the
MPTP group (p,0.01 vs. NS, Figure 5B). 100 Hz EA stimulation
significantly decreased GSH-PX activity at that time point
(p,0.01 vs. NS group). On day 7, high levels of GSH-PX activity
were still seen in the MPTP treated mice (13.3% increase
compared to NS group, Figure 5B) but EA stimulation normalized
GSH-PX activity in model mice. On day 14, MPTP and EA
stimulation had no effect on GSH-PX activity.
SOD activity was decreased in the striatum of MPTP treated
mice on all of the three time points, i.e., day 3, day 7 and day 14
(6.0% , 8.3% compared to NS group, Figure 5C). 100 Hz EA
stimulation increased the SOD activity in a time dependent
manner, i.e., 3 sessions (day 3) of treatment did not affect SOD
activity, 6 sessions (day 7) significantly increased SOD activity
(8.8% increase compared to EA group on day 3, p,0.01 vs. MPTP
group on day 7, Figure 5C) and 12 sessions (day 14) of treatment
also increased SOD activity too.
Figure 3. 100 Hz EA stimulation increases the contents of striatal DA and its metabolites in MPTP-treated mice. (A) DA. (B) DOPAC. (C)
HVA. ***p,0.001, compared with NS group; #p,0.05, compared with MPTP group. n=6,9.
doi:10.1371/journal.pone.0019790.g003
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MDA content
MDA is one of the final products of polyunsaturated fatty acid
peroxidation in cells. An increase in free radicals causes
overproduction of MDA. Therefore, it is used as a lipid
peroxidation marker. We detected striatal MDA content on day
7 and 14, the 1
st and 8
th day after the last MPTP injection
respectively. On day 7, MDA levels were significantly increased in
MPTP treated mice (155% increase, p,0.001 vs. NS group,
Figure 5D) but EA stimulation reduced this increase (38%
decrease, p,0.01 vs. MPTP group on day 7). On day 14 there
were no statistic differences among the three groups. Moreover,
we found there was no significant change of MDA levels in the
ventral midbrain of the model mice compared with the NS group
(Figure S5).
100 Hz EA stimulation does not affect MPP
+ metabolism
In the brain the toxicity of MPTP is due to its toxic form, MPP
+,
which is selectively toxic to dopaminergic neurons. We evaluated if
the antioxidative effect of EA stimulation was related to the
formation or degradation of MPP
+. On day 2 and day 6 when the
1
st and 5
th MPTP injections were performed, mice were killed for
the analysis of striatal MPP
+ content by HPLC-UV. Our data
shows that EA stimulation does not influence the concentration of
MPP
+ in the striatum of the MPTP treated mice (Figure 6),
suggesting that the target of EA stimulation at 100 Hz does not
involve in the MPP
+ metabolic pathway.
Discussion
More and more people turn to acupuncture for the treatment of
Parkinson’s disease and clinical evidence has proven the
effectiveness of acupuncture in the management of this dread
disease. But the underlying mechanism still needs to be clarified.
In this study we found that 100 Hz, but not 0 Hz of EA
stimulation at ST36 and SP6 can protect dopaminergic neurons in
the substantia nigra from MPTP insult, suggesting that the
response of the body to EA stimulation is frequency-dependent.
Although multiple mechanisms may be involved in this process,
our findings highlight the possibility that the antioxidative effect of
Figure 4. 100 Hz EA stimulation inhibits the elevation of
striatal H2O2 level in MPTP-treated mice. *p,0.05, compared with
NS group; #p,0.05, compared with MPTP group. n=5,8.
doi:10.1371/journal.pone.0019790.g004
Figure 5. 100 Hz EA stimulation effects on the content/activity of GSH, GSH-PX, SOD and MDA in the striatum. Saline group (gray bar),
MPTP group (white bar) and 100 Hz + MPTP group (black bar). (A) GSH content. (B) GSH-PX activity. (C) SOD activity. (D) MDA content. **p,0.01,
***p,0.001, compared with NS group; ##p,0.01, ###p,0.001, compared with MPTP group on the same day. n=6,7 (A and B) or n=5,7 (C and
D).
doi:10.1371/journal.pone.0019790.g005
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involved in dopaminergic neuronal injury in MPTP-lesioned mice.
EA at 100 Hz reverses the elevation of striatal MDA concentration
in PD model mice. This antioxidative activity of EA partially relies
on its ability to reduce H2O2 content and elevate GSH level and
total SOD activity. This activity also depends on frequency
because 0 Hz EA stimulation did not benefit PD mice. In addition,
100 Hz EA stimulation did not adversely affect normal mice.
In tissues obtained at autopsy from PD patients the activity of
SOD is increased, while GSH-PX activity and GSH content are
decreased [28–30]. SOD is often regarded as the first line of
defense against an upswing of reactive oxygen species (ROS) and
responsible for the conversion of superoxide to H2O2 in the
cytoplasm and mitochondria. Enhanced SOD activity may be
neuroprotective since transgenic mice with increased SOD activity
are resistant to MPTP injury [31,32], while mice with decreased
SOD activity are more susceptible to MPTP toxicity [10,33]. GSH
is considered to be a major antioxidant in the brain, capable of
attenuating oxidative damage [34]. Impairment of the GSH
system may trigger a cascade of events leading to oxidative stress
and destruction of the nigrostriatal pathway as well as render the
pathway susceptible to a toxic insult [35]. GSH depletion is a
primary event in incidental Lewy body disease which is thought to
be presymptomatic Parkinson’s disease. GSH-PX is an enzyme of
major importance in the detoxification of peroxides such as H2O2.
Deficiency of GSH-PX activity leads to aggravating MPTP lesions
[10]. Ebselen, an antioxidant drug with GSH-PX-like activity,
prevents both neuronal loss and clinical symptoms in a primate
MPTP model of PD [13].
Our findings reveal that 100 Hz EA stimulation at ST36 and
SP6 can prevent the decrease of striatal total SOD activity, elevate
striatal GSH concentration, and consequently inhibit the increase
of striatal H2O2 and MDA level caused by MPTP. On day 3 (3
sessions of EA) the decrease of striatal GSH-PX activity in the EA
group might relate to the augmented striatal GSH content, which
helps to consume the excessive H2O2.
Recently, Yu et al. claimed that acupuncture mitigated
oxidative stress in the SN of 6-hydroxydopamine lesioned rats
[36]. Compared with their study we used MPTP mice model,
which is the best available and the most popular animal model of
PD at present [7,9,37–41]. Furthermore, we detected the
oxidative indicators in a time-course manner (on day 3, 7 and
14), and illustrated a picture on the oxidative changes in MPTP
mice model. In our model the rapid elevation of H2O2 content
and GSH-PX activity suggests that the production of ROS is an
early event in MPTP toxicity, consistent with the observations in
other experiments [42,43]. Also, our study suggested that
oxidative stress could be more profound in the striatum than
that in the ventral midbrain, which might be due to the fact that
the DA neuron loss induced by MPTP results from molecular
events initiated in the striatum [44–46]. Thus, the antioxidative
effect of EA at these two acupoints on the striatum could be
significant to rescue the DA neurons in the SN. Kim et al. found
that 100 Hz EA normalized the elevation of glyoxalase II, which
plays a pro-survival role in the metabolic stress response through
detoxifying methylglyoxal in MPTP mice, and they assumed that
it could be due to the relief of oxidative stress in the striatum by
increasing antioxidant enzyme activities, thereby precluding
methylglyoxal accumulation [47].
Motor behavioral abnormality is the cardinal characteristics of
human PD. Therefore, therapies that can improve the abnormal
behavior will significantly help PD patients in their daily life. In
this study we found that 100 Hz EA stimulation normalized the
motor disorders of the model mice. We think that the mechanism
is due to the regulatory effect of EA on other nuclei in the basal
ganglia, such as the globus pallidus, but not the neuroprotective
effect of EA on the dopaminergic neurons in the nigrostriatal
system (Wang HM et al. unpublished). It is in accordance with the
previous studies in our lab [48–50].
MPP
+ activates microglia which exaggerates its toxicity via
ROS dependent and independent mechanisms [51]. Our previous
work revealed that 100 Hz EA stimulation can suppress the
activation of microglia and up-regulate BDNF and GDNF
expression in medial forebrain bundle-transected PD rats
[22,50,52]. Therefore, 100 Hz EA stimulation might rescue DA
neurons through multiple ways besides mitigating oxidative stress
in MPTP mice. Indeed, we have discovered that 100 Hz EA
stimulation at ST36 and SP6 has an anti-apoptotic effect by
elevating the Bcl-2/Bax ratio in this model (Pan YL et al.,
unpublished).
In its late stage PD destroys multiple regions of the brain except
for the nigrostriatal system, which leads to complex clinical
symptoms such as pain and insomnia. A clinical report
demonstrated that acupuncture benefited the sleep of PD patients
and eased the patients ` subjective sufferings from pain [53]
suggesting that acupuncture stimulation produces extensive
neuroprotective and regulative effects. Therefore, it is highly
possible that the integration of several activated signal pathways
during acupuncture stimulation plays a role in alleviating the
pathological changes in the brain of PD patients.
Supporting Information
Figure S1 Time course of striatal H2O2 levels after a
single injection of MPTP. ** p,0.01, ***p,0.001, compared
with NS group. n=5,7.
(TIF)
Figure S2 Time course of H2O2 contents in the striatum
of the subacute MPTP mouse model. *p,0.05, **p,0.01,
compared with NS group. n=6.
(TIF)
Figure S3 Time course of H2O2 levels in the ventral
midbrain after a single injection of MPTP. Animals were
sacrificed at 2, 4, 6, 8, 10 and 12 hours post one MPTP injection
(30 mg/kg, i.p.). H2O2 contents of the ventral midbrains were
detected. n=5,7.
(TIF)
Figure 6. 100 Hz EA stimulation does not affect MPP
+
formation. MPTP group (white bar) and 100 Hz + MPTP group (black
bar). n=6,8.
doi:10.1371/journal.pone.0019790.g006
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midbrain of the subacute MPTP mouse model. At 4 hours
after the 2
nd,3
rd,4
th and 5
th MPTP injection (30 mg/kg, i.p.),
animals were decapitated. Contents of H2O2 in the ventral
midbrains were detected. n=6.
(TIF)
Figure S5 Time course of MDA contents in the ventral
midbrain of the subacute MPTP mouse model. After the
2
nd,3
rd,4
th and 5
th MPTP injection (30 mg/kg, i.p.), animals were
decapitated. Contents of MDA in the ventral midbrains were
detected. n=6.
(TIF)
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